Status:
COMPLETED
A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Hypertension
Eligibility:
All Genders
18-110 years
Phase:
NA
Brief Summary
The long-term objective is to determine whether better adherence to prescribed medications can be achieved through positive affect induction and self-affirmation leading to reduction in hypertension-r...
Detailed Description
The objective of this randomized trial is to evaluate, among African American patients with poorly controlled hypertension, whether a novel intervention of positive affect induction and self-affirmati...
Eligibility Criteria
Inclusion
- Patients must be self-identified as African-Americans.
- All patients must be aged 18 years and older.
- All patients must be diagnosed as having hypertension: For this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee (JNC VI) Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, which is a systolic blood pressure \> 140 mm hg or a diastolic blood pressure \> 90 mm hg or if participants are taking any prescribed antihypertensive medication.
- Patients must be able to provide informed consent in English.
Exclusion
- Patients who are unable to walk several blocks for any reason.
- Patients who refused to participate
- Patients who are unable to provide informed consent.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT00248872
Start Date
October 1 2004
End Date
July 1 2008
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The New York Presbyterian Hospital-Weill Medical Center
New York, New York, United States, 10021